Term
|
Definition
| associated with insulin resistance (Type I or II) |
|
|
Term
|
Definition
| associated with beta-cell autoantibodies (Type I or II) |
|
|
Term
|
Definition
| most commonly occurring diabetes in the US (Type I or II) |
|
|
Term
|
Definition
| incidence increases with obesity (Type I or II) |
|
|
Term
|
Definition
| associated with diabetic ketoacidosis (DKA) (Type I or II) |
|
|
Term
|
Definition
| associated with HHNK syndrome (Type I or II) |
|
|
Term
|
Definition
| associated with intracellular sorbitol accumulation (Type I or II) |
|
|
Term
|
Definition
| associated with absolute requirement for daily insulin injections (Type I or II) |
|
|
Term
|
Definition
| associated with very high, sustained, hyperglycemia (Type I or II) |
|
|
Term
|
Definition
| women who experienced gestational diabetes are more likely to develop… (Type I or II) |
|
|
Term
|
Definition
| associated with vision loss due to diabetic retinopathy (Type I or II) |
|
|
Term
|
Definition
| inhibits digestion of starch and disaccharides |
|
|
Term
|
Definition
| increases expression of glucose transporters in muscle and adipose cells |
|
|
Term
|
Definition
| stimulates increased secretion of insulin |
|
|
Term
|
Definition
| decreases hepatic glucose production |
|
|
Term
|
Definition
| increases sensitivity of beta-cells to blood glucose levels |
|
|
Term
|
Definition
| inhibits breakdown of incretins |
|
|